Search

everythinglearnresearchcommunity

for

Search:↓

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Improving skin barrier and using antifungal treatments can help manage dandruff.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Online medical education helps doctors make better clinical decisions and increases their knowledge in treating fungal nail infections.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

No treatment fully prevents hair loss from chemotherapy yet.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Albendazole may cause hair loss.

Innovative methods are reducing animal testing and improving biomedical research.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.